Discrepancy Between Pulmonary Artery Catheter and Co-Oximeter Value of Mixed Venous Oxygen Saturation After Graft Reperfusion During Living Donor Liver Transplantation

IF 0.8 4区 医学 Q4 IMMUNOLOGY Transplantation proceedings Pub Date : 2024-12-01 DOI:10.1016/j.transproceed.2024.11.015
Yeonji Noh, Jeayoun Kim, Sooyeon Lee, Jisun Choi, Gaab Soo Kim
{"title":"Discrepancy Between Pulmonary Artery Catheter and Co-Oximeter Value of Mixed Venous Oxygen Saturation After Graft Reperfusion During Living Donor Liver Transplantation","authors":"Yeonji Noh,&nbsp;Jeayoun Kim,&nbsp;Sooyeon Lee,&nbsp;Jisun Choi,&nbsp;Gaab Soo Kim","doi":"10.1016/j.transproceed.2024.11.015","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Monitoring tissue oxygenation is critical in liver recipients. The pulmonary artery catheter (PAC) provides continuous monitoring of mixed venous oxygen saturation (SvO<sub>2</sub>) using fiberoptic reflectance spectrophotometry. Despite the need for in vivo calibration during liver transplantation, recalibration guidelines are absent, and we frequently observed a significant discrepancy between PAC and reference co-oximeter SvO<sub>2</sub> values after graft reperfusion. This study aimed to assess the incidence and risk factors of a significant discrepancy after reperfusion during living donor liver transplantation.</div></div><div><h3>Methods</h3><div>This retrospective study included 54 recipients who underwent living donor liver transplantation at our institution between October 2021 and April 2022. A PAC was inserted, and in vivo calibration was conducted using the co-oximeter SvO<sub>2</sub> value. We defined a significant discrepancy as a drift was ≥ 3% at 1 hour after reperfusion. Logistic regression analysis was performed to determine the association between perioperative variables and the risk of significant discrepancy.</div></div><div><h3>Results</h3><div>PAC SvO<sub>2</sub> was higher than co-oximeter SvO<sub>2</sub> in 51 recipients. A significant discrepancy was observed in 37 recipients (68.5%). The risk of significant discrepancy decreased with a high preoperative hemoglobin concentration (odds ratio [OR] = 0.65 [0.47–0.91], <em>P</em> = .011) and a high arterial oxygen partial pressure (PaO<sub>2</sub>) at 1 hour after reperfusion (OR = 0.96 [0.94–0.99], <em>P</em> = .004) but increased with a high baseline co-oximeter SvO<sub>2</sub> value (OR = 1.29 [1.05–1.59], <em>P</em> = .015).</div></div><div><h3>Conclusions</h3><div>PAC SvO<sub>2</sub> significantly drifted from the reference co-oximeter value in over two-thirds of recipients after reperfusion. Therefore, in vivo recalibration is required for the reliable measurement of PAC SvO<sub>2</sub> during living donor liver transplantation.</div></div>","PeriodicalId":23246,"journal":{"name":"Transplantation proceedings","volume":"56 10","pages":"Pages 2191-2195"},"PeriodicalIF":0.8000,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Transplantation proceedings","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0041134524005566","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Monitoring tissue oxygenation is critical in liver recipients. The pulmonary artery catheter (PAC) provides continuous monitoring of mixed venous oxygen saturation (SvO2) using fiberoptic reflectance spectrophotometry. Despite the need for in vivo calibration during liver transplantation, recalibration guidelines are absent, and we frequently observed a significant discrepancy between PAC and reference co-oximeter SvO2 values after graft reperfusion. This study aimed to assess the incidence and risk factors of a significant discrepancy after reperfusion during living donor liver transplantation.

Methods

This retrospective study included 54 recipients who underwent living donor liver transplantation at our institution between October 2021 and April 2022. A PAC was inserted, and in vivo calibration was conducted using the co-oximeter SvO2 value. We defined a significant discrepancy as a drift was ≥ 3% at 1 hour after reperfusion. Logistic regression analysis was performed to determine the association between perioperative variables and the risk of significant discrepancy.

Results

PAC SvO2 was higher than co-oximeter SvO2 in 51 recipients. A significant discrepancy was observed in 37 recipients (68.5%). The risk of significant discrepancy decreased with a high preoperative hemoglobin concentration (odds ratio [OR] = 0.65 [0.47–0.91], P = .011) and a high arterial oxygen partial pressure (PaO2) at 1 hour after reperfusion (OR = 0.96 [0.94–0.99], P = .004) but increased with a high baseline co-oximeter SvO2 value (OR = 1.29 [1.05–1.59], P = .015).

Conclusions

PAC SvO2 significantly drifted from the reference co-oximeter value in over two-thirds of recipients after reperfusion. Therefore, in vivo recalibration is required for the reliable measurement of PAC SvO2 during living donor liver transplantation.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
活体肝移植再灌注后肺动脉导管与共氧仪混合静脉血氧饱和度的差异。
背景:监测组织氧合对肝脏受者至关重要。肺动脉导管(PAC)使用光纤反射分光光度法连续监测混合静脉氧饱和度(SvO2)。尽管在肝移植过程中需要进行体内校准,但缺乏再校准指南,我们经常观察到移植物再灌注后PAC和参考共氧仪SvO2值之间存在显着差异。本研究旨在评估活体肝移植再灌注后显著差异的发生率及危险因素。方法:本回顾性研究纳入了2021年10月至2022年4月期间在我院接受活体肝移植的54例受者。插入PAC,并使用共氧仪SvO2值进行体内校准。我们将显著差异定义为再灌注后1小时漂移≥3%。通过Logistic回归分析确定围手术期变量与显著差异风险的相关性。结果:51例患者PAC SvO2高于共血氧计SvO2。37例(68.5%)患者存在显著差异。术前较高的血红蛋白浓度(比值比[OR] = 0.65 [0.47-0.91], P = 0.011)和再灌注后1小时较高的动脉血氧分压(PaO2) (OR = 0.96 [0.94-0.99], P = 0.004)降低了显著差异的风险,但较高的基线共氧仪SvO2值(OR = 1.29 [1.05-1.59], P = 0.015)增加了显著差异的风险。结论:在再灌注后,超过三分之二的受者PAC SvO2明显偏离参考共氧仪值。因此,在活体供肝移植期间,需要在体内重新校准PAC SvO2的可靠测量。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Transplantation proceedings
Transplantation proceedings 医学-免疫学
CiteScore
1.70
自引率
0.00%
发文量
502
审稿时长
60 days
期刊介绍: Transplantation Proceedings publishes several different categories of manuscripts, all of which undergo extensive peer review by recognized authorities in the field prior to their acceptance for publication. The first type of manuscripts consists of sets of papers providing an in-depth expression of the current state of the art in various rapidly developing components of world transplantation biology and medicine. These manuscripts emanate from congresses of the affiliated transplantation societies, from Symposia sponsored by the Societies, as well as special Conferences and Workshops covering related topics. Transplantation Proceedings also publishes several special sections including publication of Clinical Transplantation Proceedings, being rapid original contributions of preclinical and clinical experiences. These manuscripts undergo review by members of the Editorial Board. Original basic or clinical science articles, clinical trials and case studies can be submitted to the journal?s open access companion title Transplantation Reports.
期刊最新文献
Contents Editorial Board Author Index Liver Transplantation in the Philippines: Light at the End of the Tunnel Current Status and Development of Rat DCD Renal Transplantation Model
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1